Who owns SCRIBE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Scribe Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Scribe Therapeutics stock

Who bought or sold SCRIBE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Tema Etfs 3.0k $56k 100% Sep 2026
 View chart
Sterling Capital Management 269.00 $5.0k 100% Sep 2026
 View chart